X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK vs ABBOTT INDIA - Comparison Results

MERCK    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK ABBOTT INDIA MERCK/
ABBOTT INDIA
 
P/E (TTM) x 56.3 35.9 156.6% View Chart
P/BV x 9.8 9.3 105.9% View Chart
Dividend Yield % 0.3 0.7 46.4%  

Financials

 MERCK   ABBOTT INDIA
EQUITY SHARE DATA
    MERCK
Dec-17
ABBOTT INDIA
Mar-18
MERCK/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,3586,110 22.2%   
Low Rs9333,996 23.3%   
Sales per share (Unadj.) Rs665.01,552.2 42.8%  
Earnings per share (Unadj.) Rs56.6188.8 30.0%  
Cash flow per share (Unadj.) Rs72.5196.4 36.9%  
Dividends per share (Unadj.) Rs15.0055.00 27.3%  
Dividend yield (eoy) %1.31.1 120.3%  
Book value per share (Unadj.) Rs441.7796.6 55.5%  
Shares outstanding (eoy) m16.6021.25 78.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.3 52.9%   
Avg P/E ratio x20.226.8 75.6%  
P/CF ratio (eoy) x15.825.7 61.4%  
Price / Book Value ratio x2.66.3 40.9%  
Dividend payout %26.529.1 91.0%   
Avg Mkt Cap Rs m19,011107,376 17.7%   
No. of employees `0001.53.3 46.5%   
Total wages/salary Rs m1,6963,937 43.1%   
Avg. sales/employee Rs Th7,150.09,929.3 72.0%   
Avg. wages/employee Rs Th1,098.71,185.1 92.7%   
Avg. net profit/employee Rs Th608.21,207.7 50.4%   
INCOME DATA
Net Sales Rs m11,04032,985 33.5%  
Other income Rs m2401,170 20.5%   
Total revenues Rs m11,27934,155 33.0%   
Gross profit Rs m1,3765,245 26.2%  
Depreciation Rs m264162 163.1%   
Interest Rs m038 0.0%   
Profit before tax Rs m1,3526,215 21.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5832,203 26.5%   
Profit after tax Rs m9394,012 23.4%  
Gross profit margin %12.515.9 78.4%  
Effective tax rate %43.135.4 121.6%   
Net profit margin %8.512.2 69.9%  
BALANCE SHEET DATA
Current assets Rs m7,52322,655 33.2%   
Current liabilities Rs m2,2536,681 33.7%   
Net working cap to sales %47.748.4 98.6%  
Current ratio x3.33.4 98.5%  
Inventory Days Days5265 80.5%  
Debtors Days Days4129 139.1%  
Net fixed assets Rs m1,240835 148.4%   
Share capital Rs m166213 78.1%   
"Free" reserves Rs m7,16716,715 42.9%   
Net worth Rs m7,33316,928 43.3%   
Long term debt Rs m00-   
Total assets Rs m9,91224,162 41.0%  
Interest coverage xNM163.7-  
Debt to equity ratio x00-  
Sales to assets ratio x1.11.4 81.6%   
Return on assets %9.516.8 56.5%  
Return on equity %12.823.7 54.0%  
Return on capital %20.836.9 56.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,015369 275.3%   
Fx outflow Rs m3,0433,807 79.9%   
Net fx Rs m-2,028-3,438 59.0%   
CASH FLOW
From Operations Rs m5371,527 35.1%  
From Investments Rs m-476-2,148 22.2%  
From Financial Activity Rs m-220-1,024 21.5%  
Net Cashflow Rs m-160-1,646 9.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 75.0 69.1%  
Indian inst/Mut Fund % 18.2 7.9 230.4%  
FIIs % 1.0 0.1 1,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 17.1 170.2%  
Shareholders   28,591 18,270 156.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK With:   ORCHID PHARMA LTD  CIPLA  ASTRAZENECA PHARMA  SUVEN LIFESCIENCES  STERLING BIOTECH  

Compare MERCK With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

US China Trade War Escalations and Election Results: Volatility Set to Rule(Podcast)

India could be the latest direct victim of the US-China trade war. The increasing escalations have already slowed down global growth.

Related Views on News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

Limited Upside, Higher Downside(The Honest Truth)

May 6, 2019

The market's irrational reaction may present opportunities for a limited period of time.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MERCK SHARE PRICE


May 17, 2019 (Close)

TRACK MERCK

MERCK - SHASUN PHARMA COMPARISON

COMPARE MERCK WITH

MARKET STATS